Clinical Trial Update: Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating capecitabine plus aflibercept as maintenance therapy after capecitabine/oxaliplatin/aflibercept in metastatic colorectal cancer has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)
• Zaltrap (ramucirumab)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: WITHDRAWN